Concerns about liver toxicity are fueling changes for pemoline and Cymbalta

Concerns about liver toxicity are fueling changes for pemoline and Cymbalta.

Pemoline will go off the market...due to liver failure.

Your patients can continue to receive pemoline until it runs out. But switch to a different ADHD med as soon as possible.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote